Pliant Therapeutics Inc (PLRX)
13.45
-0.32
(-2.32%)
USD |
NASDAQ |
Nov 14, 11:03
Pliant Therapeutics Price to Book Value: 2.367 for Nov. 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 2.423 |
| November 12, 2024 | 2.432 |
| November 11, 2024 | 2.553 |
| November 08, 2024 | 2.640 |
| November 07, 2024 | 2.673 |
| November 06, 2024 | 2.763 |
| November 05, 2024 | 2.622 |
| November 04, 2024 | 2.550 |
| November 01, 2024 | 2.555 |
| October 31, 2024 | 2.476 |
| October 30, 2024 | 2.536 |
| October 29, 2024 | 2.590 |
| October 28, 2024 | 2.615 |
| October 25, 2024 | 2.490 |
| October 24, 2024 | 2.407 |
| October 23, 2024 | 2.500 |
| October 22, 2024 | 2.574 |
| October 21, 2024 | 2.580 |
| October 18, 2024 | 2.674 |
| October 17, 2024 | 2.581 |
| October 16, 2024 | 2.660 |
| October 15, 2024 | 2.463 |
| October 14, 2024 | 2.416 |
| October 11, 2024 | 2.402 |
| October 10, 2024 | 2.041 |
| Date | Value |
|---|---|
| October 09, 2024 | 2.02 |
| October 08, 2024 | 1.978 |
| October 07, 2024 | 1.957 |
| October 04, 2024 | 2.029 |
| October 03, 2024 | 1.957 |
| October 02, 2024 | 1.920 |
| October 01, 2024 | 1.856 |
| September 30, 2024 | 1.972 |
| September 27, 2024 | 1.751 |
| September 26, 2024 | 1.730 |
| September 25, 2024 | 1.754 |
| September 24, 2024 | 1.754 |
| September 23, 2024 | 1.753 |
| September 20, 2024 | 1.880 |
| September 19, 2024 | 1.954 |
| September 18, 2024 | 1.936 |
| September 17, 2024 | 1.951 |
| September 16, 2024 | 1.838 |
| September 13, 2024 | 1.858 |
| September 12, 2024 | 1.833 |
| September 11, 2024 | 1.898 |
| September 10, 2024 | 2.010 |
| September 09, 2024 | 1.994 |
| September 06, 2024 | 1.993 |
| September 05, 2024 | 2.067 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8554
Minimum
May 11 2022
7.982
Maximum
Sep 14 2022
2.924
Average
2.579
Median
Price to Book Value Benchmarks
| Haemonetics Corp | 5.284 |
| Marker Therapeutics Inc | 3.550 |
| Aligos Therapeutics Inc | 1.380 |
| Korro Bio Inc | 2.628 |
| CEL-SCI Corp | 4.282 |
Price to Book Value Related Metrics
| PS Ratio | 161.34 |
| Price | 13.45 |
| Earnings Yield | -24.83% |
| Market Cap | 818.48M |